Labad, Jesseca D.
HRN: 13-18-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
AMPICILLIN 1GM (VIAL)
08/25/2025
08/26/2025
IV
2 Grams
Q6
PPROM
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines